| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.3 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |